Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer, July 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 360 articles:
HTML format


 

Single Articles

  1. AO L, Shi J, Gan J, Yu W, et al
    Effects of dexmedetomidine and ketorolac applied for patient?controlled analgesia on the balance of Th1/Th2 and level of VEGF in patients undergoing laparoscopic surgery for cervical cancer: A randomized controlled trial.
    Oncol Lett. 2024;28:379.
    PubMed    
    Abstract available

  2. SSEDYABANE F, Obuku EA, Namisango E, Ngonzi J, et al
    The diagnostic accuracy of serum and plasma microRNAs in detection of cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol Rep. 2024;54:101424.
    PubMed    
    Abstract available

  3. CAO D, Dong Q
    Predictive value of prognostic nutritional index for outcomes of cervical cancer: A systematic review and meta?analysis.
    Exp Ther Med. 2024;28:316.
    PubMed    
    Abstract available

  4. ZHOU Y, Wang X, Li Y, Zhang W, et al
    When synchronous mucinous metaplasia and neoplasia of the female genital tract and peutz-jeghers syndrome meet: a case report and literature reviews.
    BMC Womens Health. 2024;24:375.
    PubMed    
    Abstract available

  5. SACHDEVA M, Datchoua AM, Yakam VF, Kenfack B, et al
    Acceptability of artificial intelligence for cervical cancer screening in Dschang, Cameroon: a qualitative study on patient perspectives.
    Reprod Health. 2024;21:92.
    PubMed    
    Abstract available

  6. ZHAO Z, Yan P, Zhang X, Yu X, et al
    Causal role of immune cells on cervical cancer onset revealed by two-sample Mendelian randomization study.
    Sci Rep. 2024;14:14890.
    PubMed    
    Abstract available

  7. CHO YA, Park CK, Kim HS
    Ovarian Metastasis from Human Papillomavirus-associated Usual-type Endocervical Adenocarcinoma: Clinicopathological Characteristics for Distinguishing from Primary Ovarian Mucinous or Endometrioid Tumor.
    In Vivo. 2024;38:1973-1983.
    PubMed    
    Abstract available

  8. PENG C, Wang Y, Guo Y, Li J, et al
    A literature review on signaling pathways of cervical cancer cell death-apoptosis induced by Traditional Chinese Medicine.
    J Ethnopharmacol. 2024 Jun 25:118491. doi: 10.1016/j.jep.2024.118491.
    PubMed    
    Abstract available

  9. SHINKAFI-BAGUDU Z
    Renewed Commitments to Eliminate Cervical Cancer: What This Means for Low- and Middle-Income Countries.
    JCO Glob Oncol. 2024;10:e2400147.
    PubMed    
    Abstract available

  10. AGGARWAL A, Gupta N, Barua M, Jani KK, et al
    Gay and Bisexual Men too should not be Left Out/Deprived of Human Papilloma Virus Vaccination in "Cervical Cancer Elimination Programme" in Countries with a High Prevalence of HIV.
    Indian J Public Health. 2023;67:686.
    PubMed    


  11. KAUSHAL R, Patel M, Bhardwaj P, Gupta M, et al
    Comparison of Knowledge, Attitude, and Practices of Nursing Staff Regarding Cervical Cancer Screening at Various Levels of Health Care Facilities in Western India.
    Indian J Community Med. 2024;49:529-531.
    PubMed    
    Abstract available

  12. ZHAO Q, Yang S, Hao S, Chen Z, et al
    Identification of transcriptionally-active human papillomavirus integrants through nanopore sequencing reveals viable targets for gene therapy against cervical cancer.
    J Med Virol. 2024;96:e29769.
    PubMed    
    Abstract available

  13. MOSHI JM, Sohaili A, Moafa HN, Hakami AMS, et al
    Short Communication: Understanding the Barriers to Cervical Cancer Prevention and HPV Vaccination in Saudi Arabia.
    Viruses. 2024;16:974.
    PubMed    
    Abstract available

  14. GALATI L, Di Bonito P, Marinaro M, Chiantore MV, et al
    HPV16 Phylogenetic Variants in Anogenital and Head and Neck Cancers: State of the Art and Perspectives.
    Viruses. 2024;16:904.
    PubMed    
    Abstract available

  15. CASTRILLO-DIEZ JL, Rivera-Santiago C, Avila-Flores SM, Barrera-Barrera SA, et al
    Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico.
    Viruses. 2024;16:887.
    PubMed    
    Abstract available

  16. PERGIALIOTIS V, Rodolakis I, Rodolakis A, Thomakos N, et al
    Controversies and Advances in the Personalized Surgical Treatment of Cervical Cancer.
    J Pers Med. 2024;14:606.
    PubMed    
    Abstract available

  17. DICU-ANDREESCU IG, Marincas MA, Simionescu AA, Dicu-Andreescu I, et al
    Abdominal Parietal Metastasis from Cervical Cancer: A Review of One of the Most Uncommon Sites of Recurrence Including a Report of a New Case.
    Life (Basel). 2024;14:667.
    PubMed    
    Abstract available

  18. NIKOLIC N, Basica B, Strbac M, Terzic L, et al
    Prevalence of Carcinogenic Genotypes of HPV-Infected Women in a Ten-Year Period (2014-2023) in Vojvodina, Serbia.
    Medicina (Kaunas). 2024;60:922.
    PubMed    
    Abstract available

  19. BALAN L, Secosan C, Sorop VB, Pirtea M, et al
    Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study.
    Medicina (Kaunas). 2024;60:909.
    PubMed    
    Abstract available

  20. DICU-ANDREESCU IG, Marincas MA, Simionescu AA, Dicu-Andreescu I, et al
    The Role of Lymph Node Downstaging Following Neoadjuvant Treatment in a Group of Patients with Advanced Stage Cervical Cancer.
    Medicina (Kaunas). 2024;60:871.
    PubMed    
    Abstract available

  21. KIRSCH-MANGU AT, Pop DC, Tipcu A, Andries AI, et al
    CT Angiography-Guided Needle Insertion for Interstitial Brachytherapy in Locally Advanced Cervical Cancer.
    Diagnostics (Basel). 2024;14:1267.
    PubMed    
    Abstract available

  22. MIAZGA W, Tatara T, Wnuk K, Gujski M, et al
    The Impact of Urine-Sample HPV Testing on the Effectiveness of Screening for Cervical Cancer: An Umbrella Review.
    Cancers (Basel). 2024;16:2244.
    PubMed    
    Abstract available

  23. CATALAN-CASTORENA O, Garibay-Cerdenares OL, Illades-Aguiar B, Castillo-Sanchez R, et al
    Bioinformatics Analysis of Human Papillomavirus 16 Integration in Cervical Cancer: Changes in MAGI-1 Expression in Premalignant Lesions and Invasive Carcinoma.
    Cancers (Basel). 2024;16:2225.
    PubMed    
    Abstract available

  24. CARDOSO-CARNEIRO D, Pinheiro J, Fontao P, Nogueira R, et al
    Unveiling the RKIP and EGFR Inverse Relationship in Solid Tumors: A Case Study in Cervical Cancer.
    Cancers (Basel). 2024;16:2182.
    PubMed    
    Abstract available

  25. ANDO Y, Cho J, Park NJ, Ko S, et al
    Toward Interpretable Cell Image Representation and Abnormality Scoring for Cervical Cancer Screening Using Pap Smears.
    Bioengineering (Basel). 2024;11:567.
    PubMed    
    Abstract available

  26. VELIMIROVICI MD, Feier CVI, Vonica RC, Faur AM, et al
    Efficacy and Safety of Atezolizumab as a PD-L1 Inhibitor in the Treatment of Cervical Cancer: A Systematic Review.
    Biomedicines. 2024;12:1291.
    PubMed    
    Abstract available

  27. AHMADI M, Abdollahi R, Otogara M, Taherkhani A, et al
    Exploring molecular targets: herbal isolates in cervical cancer therapy.
    Genomics Inform. 2024;22:9.
    PubMed    
    Abstract available

  28. DILLNER J, Muhr LSA, Kleppe SN, Wang J, et al
    The Swedish Cervical Screening Cohort.
    Sci Data. 2024;11:697.
    PubMed    
    Abstract available

  29. CHOI EY, Han EJ, Jeon SJ, Lee SW, et al
    Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via Inactivation of the PI3K/AKT/mTOR Signaling Pathway.
    Anticancer Res. 2024;44:2961-2972.
    PubMed    
    Abstract available

  30. MAFUNE S, Someya M, Hasegawa T, Tsuchiya T, et al
    Analysis of Treatment Response With Proteins Related to Tumor Immunity in Postoperative Irradiated Cervical Cancer Patients.
    Anticancer Res. 2024;44:3077-3086.
    PubMed    
    Abstract available

  31. ZHANG Y, Niu X, Wang Y, Bao S, et al
    SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis.
    Anticancer Res. 2024;44:2861-2870.
    PubMed    
    Abstract available

  32. LOGEL M, El-Zein M, Franco EL, Gonzalez E, et al
    Species-level characterization of the cervicovaginal microbiota and its role in human papillomavirus-associated cervical carcinogenesis.
    J Med Virol. 2024;96:e29764.
    PubMed    
    Abstract available

  33. FOBIAN SF, Mei X, Crezee J, Snoek BC, et al
    Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review.
    J Med Virol. 2024;96:e29741.
    PubMed    
    Abstract available

  34. ZHOU D, Chen D, Wu J, Feng T, et al
    Dicerandrol C Suppresses Proliferation and Induces Apoptosis of HepG2 and Hela Cancer Cells by Inhibiting Wnt/beta-Catenin Signaling Pathway.
    Mar Drugs. 2024;22:278.
    PubMed    
    Abstract available

  35. MATHIS A, Smith UD, Crowther V, Lee T, et al
    An Epidemiological Study of Cervical Cancer Trends among Women with Human Immunodeficiency Virus.
    Healthcare (Basel). 2024;12:1178.
    PubMed    
    Abstract available

  36. ARIZMENDI-IZAZAGA A, Navarro-Tito N, Jimenez-Wences H, Evaristo-Priego A, et al
    Bioinformatics Analysis Reveals E6 and E7 of HPV 16 Regulate Metabolic Reprogramming in Cervical Cancer, Head and Neck Cancer, and Colorectal Cancer through the PHD2-VHL-CUL2-ELOC-HIF-1alpha Axis.
    Curr Issues Mol Biol. 2024;46:6199-6222.
    PubMed    
    Abstract available

  37. ELIT L, Manjuh F, Kila L, Suika B, et al
    Mother-Child Approach to Cervical Cancer Prevention in a Low Resource Setting: The Cameroon Baptist Convention Health Services Story.
    Curr Oncol. 2024;31:3227-3238.
    PubMed    
    Abstract available

  38. YU JH, Yuan HB, Yan ZY, Zhang X, et al
    The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation.
    Front Immunol. 2024;15:1421778.
    PubMed    
    Abstract available

  39. MUHAMMAD ZB, Ezenkwa US, Imoudu IA, Katagum DA, et al
    Cervical cancer awareness, perception, and attitude among tertiary health institution students in northeastern Nigeria.
    Front Oncol. 2024;14:1415627.
    PubMed    
    Abstract available

  40. DEGAREGE A, Madhivanan P
    Methodological Assessment of a Review of Knowledge, Attitude and Practice about Human Papilloma Virus Vaccination in India.
    Asian Pac J Cancer Prev. 2024;25:1857-1859.
    PubMed    


  41. SHANKAR A, Brixey-Watts K, Roy S, Saini D, et al
    Faking Death for Cervical Cancer Awareness: Is It Justified?
    Asian Pac J Cancer Prev. 2024;25:1851-1853.
    PubMed    


  42. BASU P, Mwanahamuntu M, Pinder LF, Muwonge R, et al
    A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial.
    Nat Med. 2024 Jun 25. doi: 10.1038/s41591-024-03080.
    PubMed    
    Abstract available

  43. LEE J, Kim DJ, Lee HJ
    Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort.
    Sci Rep. 2024;14:14619.
    PubMed    
    Abstract available

  44. YU C, Wang J, Li Y
    TRIM8 Promotes Proliferation, Invasion, and Migration of Cervical Cancer Cells by Ubiquitinating and Degrading SOCS1.
    Biochem Genet. 2024 Jun 25. doi: 10.1007/s10528-024-10865.
    PubMed    
    Abstract available

  45. CHUNG PYJ, Dhillon SK, Cortoos S, Hamerlinck H, et al
    Evaluation of the Allplex HPV assay's adherence to international guidelines for cervical cancer screening in clinician-collected samples.
    Microbiol Spectr. 2024 Jun 25:e0033224. doi: 10.1128/spectrum.00332.
    PubMed    
    Abstract available

  46. FONTENOT VE, Francoeur A, Tewari K
    Review of emerging biological therapies for recurrent and advanced metastatic cervical cancer.
    Expert Opin Biol Ther. 2024 Jun 25. doi: 10.1080/14712598.2024.2373320.
    PubMed    


  47. QIN HE, Peng L, Xu YC, Zhang ZX, et al
    GuiErBai: a potent inhibitor, exhibiting broadly antitumor effect against cervical cancer in vitro and in vivo.
    Front Pharmacol. 2024;15:1296588.
    PubMed    
    Abstract available

  48. REZA S, Dewan SMR, Islam MS, Shahriar M, et al
    Response of Bangladesh to the World Health Organization call to eliminate cervical cancer as a public health issue: An observational report.
    Health Sci Rep. 2024;7:e2178.
    PubMed    
    Abstract available

  49. WANG J, Wang C, Su T
    Risk factors for residual lesions after total hysterectomy in patients with high-grade cervical intraepithelial neoplasia.
    BMC Womens Health. 2024;24:369.
    PubMed    
    Abstract available

  50. LIU Y, Fang SS, Zhao RS, Liu B, et al
    Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:321.
    PubMed    
    Abstract available

  51. YAZAKI S, Chiba Y, Kojima Y, Yoshida H, et al
    Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer.
    Int J Gynecol Pathol. 2024 Jun 12. doi: 10.1097/PGP.0000000000001051.
    PubMed    
    Abstract available

  52. WU Q, Zhang L, Sun Y, Ying J, et al
    Vitamin D-Regulated miR-589-3p in Patients with Cervical Cancer Predicts Patient Prognosis and is Involved in Tumor Progression.
    Nutr Cancer. 2024 Jun 24:1-9. doi: 10.1080/01635581.2024.2365473.
    PubMed    
    Abstract available

  53. CHARGARI C, Maury P, Texier M, Genestie C, et al
    Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer.
    ACS Nano. 2024 Jun 24. doi: 10.1021/acsnano.3c12537.
    PubMed    
    Abstract available

  54. ROUHI R, Niyoteka S, Carre A, Achkar S, et al
    Automatic gross tumor volume segmentation with failure detection for safe implementation in locally advanced cervical cancer.
    Phys Imaging Radiat Oncol. 2024;30:100578.
    PubMed    
    Abstract available

  55. ANDREW-BASSEY UI, Oke DO, Okunlola MA, Morhason-Bello IO, et al
    Scoping review protocol on the perception and attitude of women on methods for collecting cervicovaginal samples for human papillomavirus testing in sub-Saharan Africa.
    BMJ Open. 2024;14:e085408.
    PubMed    
    Abstract available

  56. BERTELSEN VM, Tranberg M, Petersen LK, Booth B, et al
    Improving diagnostic of cervical dysplasia among postmenopausal women aged >/=50 years using local vaginal oestrogen treatment prior to colposcopy: study protocol for a multicentre randomised controlled trial (the IDEAL study).
    BMJ Open. 2024;14:e082833.
    PubMed    
    Abstract available

  57. YANG T, Zhao T, Ji Z, Lei R, et al
    The safety and efficacy of volumetric modulated Arc therapy combined with computer tomography-guided adaptive brachytherapy for locally advanced cervical cancer: a single institution experience.
    Radiat Oncol. 2024;19:77.
    PubMed    
    Abstract available

  58. ALCI A, Aytekin O, Ersak B, Kilic F, et al
    The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancers.
    BMC Womens Health. 2024;24:365.
    PubMed    
    Abstract available

  59. LIAO W, Li Y, Liu T, Deng J, et al
    The activation of Piezo1 channel promotes invasion and migration via the release of extracellular ATP in cervical cancer.
    Pathol Res Pract. 2024;260:155426.
    PubMed    
    Abstract available

  60. BECERRA-CANALES B, Campos-Sobrino M, Campos-Sobrino M, Martinez-Munante RD, et al
    [Visual inspection with acetic acid and the control of cervical cancer in primary care].
    Medicina (B Aires). 2024;84:526-533.
    PubMed    
    Abstract available

  61. MEDINA RUIZ L, Chahla RE, Vega IM, Ortega ES, et al
    [Artificial Intelligence: accuracy for the diagnosis of precancerous lesions of the cervix].
    Medicina (B Aires). 2024;84:459-467.
    PubMed    
    Abstract available

  62. AGENOR M, Noh M, Eiduson R, LeBlanc M, et al
    Barriers to and opportunities for advancing racial equity in cervical cancer screening in the United States.
    BMC Womens Health. 2024;24:362.
    PubMed    
    Abstract available

  63. TUERXUN G, Li W, Abudurexiti G, Zhuo Q, et al
    EPB41L3 Inhibits the Progression of Cervical Cancer Via the ERK/p38 MAPK Signaling Pathway.
    Mol Biotechnol. 2024 Jun 21. doi: 10.1007/s12033-024-01172.
    PubMed    
    Abstract available

  64. LI H, Du Z, Zhu L, Zhang C, et al
    Ultrabright NIR-IIb Fluorescence Quantum Dots for Targeted Imaging-Guided Surgery.
    ACS Appl Mater Interfaces. 2024;16:32045-32057.
    PubMed    
    Abstract available

  65. DOUBOVA SV, McClellan SP, Martinez-Vega IP, Urena-Bogarin EL, et al
    HPV Self-Sampling in the Workplace: A Qualitative Study of Benefits, Barriers, and Opportunities for Improvement Perceived by Health Professionals and Managers.
    Arch Med Res. 2024;55:103009.
    PubMed    
    Abstract available

  66. MALAGON T, Franco EL, Tejada R, Vaccarella S, et al
    Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination.
    Nat Rev Clin Oncol. 2024;21:522-538.
    PubMed    
    Abstract available

  67. MORGAN EL
    mSphere of Influence: Retreading old ground-the beauty in multi-omic data sets.
    mSphere. 2024;9:e0013124.
    PubMed    
    Abstract available

  68. BAI X, Wei J, Starr D, Zhang X, et al
    Assessment of Efficacy and Accuracy of Cervical Cytology Screening With Artificial Intelligence Assistive System.
    Mod Pathol. 2024;37:100486.
    PubMed    
    Abstract available

  69. CALAGNA G, Granese R, Giallombardo V, Capra G, et al
    Attitudes of mothers of preadolescent girls on HPV vaccine in Italy: do we need a turning point?
    Minerva Obstet Gynecol. 2024;76:222-230.
    PubMed    
    Abstract available

  70. OSEI EA, Garti I, Ani-Amponsah M, Frimpong E, et al
    Adjustment and coping in spousal caregivers of cervical cancer patients in Ghana: A qualitative phenomenological study.
    Medicine (Baltimore). 2024;103:e38807.
    PubMed    
    Abstract available

  71. WANG Z, Ren C, Yang L, Zhang X, et al
    Retraction of: Silencing of circular RNA_0000326 inhibits cervical cancer cell proliferation, migration and invasion by boosting microRNA-338-3p-dependent down-regulation of CDK4.
    Aging (Albany NY). 2024;16:10668-10669.
    PubMed    


  72. MOORE S, Kulkarni V, Moore A, Landes JR, et al
    Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells.
    Arch Dermatol Res. 2024;316:455.
    PubMed    
    Abstract available

  73. VAN DER HOEVEN NMA, van den Brule AJC, van Beekhuizen HJ, de Kok IMCM, et al
    Perspective of obstetric care-providers on being involved in cervical cancer screening during antenatal care in the Netherlands.
    Cancer Med. 2024;13:e7380.
    PubMed    
    Abstract available

  74. KUMAR KORE R, Shirbhate E, Singh V, Mishra A, et al
    New Investigational Drug's Targeting Various Molecular Pathways for Treatment of Cervical Cancer: Current Status and Future Prospects.
    Cancer Invest. 2024 Jul 5:1-16. doi: 10.1080/07357907.2024.2373841.
    PubMed    
    Abstract available

  75. SOOKAROMDEE P, Wiwanitkit V
    Assessing the Accuracy of Self-Specimen Collection in HPV Testing: Implications for Clinical Laboratory Practice.
    Clin Lab. 2024;70.
    PubMed    



  76. Correction to "Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studi
    Cancer Med. 2024;13:e7451.
    PubMed    


  77. CHENG H, Dong Y, Wang L, Zhao X, et al
    Analysis of human papillomavirus type 16 E4, E5 and L2 gene variations among women with cervical infection in Xinjiang, China.
    BMC Med Genomics. 2024;17:179.
    PubMed    
    Abstract available

  78. LIU Y, Medlege HB, Kang Y, Wu L, et al
    Clinical efficacy of a new therapeutic option for lower genital tract lesions: 5-ALA photodynamic therapy.
    Lasers Med Sci. 2024;39:172.
    PubMed    
    Abstract available

  79. BHATTACHARJEE R, Dey T, Kumar L, Kar S, et al
    Corrigendum to "Cellular landscaping of cisplatin resistance in cervical cancer" Biomed. Pharmacother. 153(2022) 113345.
    Biomed Pharmacother. 2024 Jul 4:117097. doi: 10.1016/j.biopha.2024.117097.
    PubMed    


  80. JACKSON SS, O'Callaghan S, Ward E, Orkin CM, et al
    Rationale and design of the Self-TI Study protocol: a cross-sectional human papillomavirus self-testing pilot study among transgender adults in England.
    BMJ Open. 2024;14:e086099.
    PubMed    
    Abstract available

  81. LIAO W, Liu T, Li Y, Liang H, et al
    The bioinfomatics analysis of the M1 macrophage-related gene CXCL9 signature in cervical cancer.
    J Obstet Gynaecol. 2024;44:2373951.
    PubMed    
    Abstract available

  82. WONG CL, So WKW, Chan DNS
    Community health worker-led multimedia intervention to increase cervical cancer screening uptake among South Asians: a randomised controlled trial (abridged secondary publication).
    Hong Kong Med J. 2024;30 Suppl 3:39-42.
    PubMed    


  83. SANCHEZ-RODRIGUEZ IE, Medina-Gomez YG, Balderrama-Ibarra RI, Ramos-Vega JC, et al
    Cervical Cancer in Mexico: From a Renowned Vaccination Program to Unfulfilled Needs in Treatment Access.
    Cureus. 2024;16:e61553.
    PubMed    
    Abstract available

  84. BEDI M, Kieft A, Joiner M, Miller S, et al
    Dramatic Radiographic Response of Pelvis-Filling Locally Advanced Cervical Cancer Treated With Radiation and Chemotherapy.
    Cureus. 2024;16:e61544.
    PubMed    
    Abstract available

  85. OLUMODEJI AM, Adefemi AK, Adedeji MO, Ogunyemi AA, et al
    Attitude to cervical cancer screening and human papillomavirus testing experience in self-sampled Nigerian women.
    Afr Health Sci. 2024;24:127-134.
    PubMed    
    Abstract available

  86. CHAUHAN R, Malhotra L, Gupta A, Dagar G, et al
    Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression.
    Sci Rep. 2024;14:15287.
    PubMed    
    Abstract available

  87. LING L, Chen J, Zhan L, Fu J, et al
    NLRC5 promotes tumorigenesis by regulating the PI3K/AKT signaling pathway in cervical cancer.
    Sci Rep. 2024;14:15353.
    PubMed    
    Abstract available

  88. SHEN J, Chen M, Qiu H, Yang C, et al
    Evaluation and improvement of the safety of 3D-printed template assisted intracavitary/interstitial brachytherapy for cervical cancer using repeat FMEA.
    Brachytherapy. 2024 Jul 2:S1538-4721(24)00073.
    PubMed    
    Abstract available

  89. WEI W, Fu P, Ju L, Chen L, et al
    Reminiscence Therapy-Engaged Care Exhibits a Pleasing Effect on Attenuating Psychological Burden and Bolstering Quality of Life in Elderly Postoperative Cervical Cancer Patients with Anxiety or Depression.
    Tohoku J Exp Med. 2024 Jul 4. doi: 10.1620/tjem.2024.
    PubMed    


  90. VERGOTE I, Gonzalez-Martin A, Fujiwara K, Kalbacher E, et al
    Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
    N Engl J Med. 2024;391:44-55.
    PubMed    
    Abstract available

  91. GEDA YF, Lamiso YY, Berhe TM, Mohammed SJ, et al
    Visual Inspection with Acetic Acid Positivity in Screening and Early Detection of Cervical Dysplasia in Africa, 2023: A Meta-Analysis.
    Ethiop J Health Sci. 2024;34:3-14.
    PubMed    
    Abstract available

  92. ZHONG PP, Tian C, He Y, Chen TB, et al
    [Clinicopathological analysis of atypical endocervical cells in cervical cytology].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:728-730.
    PubMed    


  93. LI Q, Zhou X, Xiao J, Gong Y, et al
    Role of ZNF334 in cervical cancer: implications for EMT reversal and tumor suppression.
    Med Oncol. 2024;41:191.
    PubMed    
    Abstract available

  94. DRYSDALE H, Marlow LAV, Lim A, Waller J, et al
    Experiences of Self-Sampling and Future Screening Preferences in Non-Attenders Who Returned an HPV Vaginal Self-Sample in the YouScreen Study: Findings From a Cross-Sectional Questionnaire.
    Health Expect. 2024;27:e14118.
    PubMed    
    Abstract available

  95. XIA C, Cai X, Li X, Chen Q, et al
    The impact of multidimensional nursing interventions on self-efficacy and quality of life in patients with cervical cancer.
    Minerva Surg. 2024 Jul 2. doi: 10.23736/S2724-5691.24.10415.
    PubMed    


  96. GUO YP, Yang Q, Wang SR, Li SM, et al
    [Value of SOX1 and PAX1 Gene Methylation Detection in Secondary Triage of High-Grade Cervical Lesions].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024;46:329-333.
    PubMed    
    Abstract available

  97. BAI H, Zheng H
    Labeled-free quantitative proteomic analysis of cervical squamous cell carcinoma identifies potential protein biomarkers.
    PeerJ. 2024;12:e17444.
    PubMed    
    Abstract available

  98. FENG Q, Shen Z, Wang F, Shi C, et al
    Mediation of circ_0007142 on miR-128-3p/S100A14 pathway to stimulate the progression of cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2024.
    PubMed    
    Abstract available

  99. LIU LY, Guo CR, Sun Y
    [Research progress of radioresistance mechanism and common sensitization methods in cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:492-496.
    PubMed    


  100. WU YZ, Ren Y, Zhong YF, Tang PP, et al
    [Analysis of adverse late-term pregnancy outcomes after cervical cold knife conization].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:447-453.
    PubMed    
    Abstract available

  101. FERGUSON S
    HPV: Cameroon fights back against one of the world's lowest vaccination rates.
    BMJ. 2024;386:q607.
    PubMed    


  102. PAVONE M, Bizzarri N, Goglia M, Lecointre L, et al
    Laparoscopic transabdominal cerclage in a pregnant woman after fertility-sparing treatment for early-stage cervical cancer: an operative technique in ten steps.
    Facts Views Vis Obgyn. 2024;16:217-223.
    PubMed    
    Abstract available

  103. GRAM EJPN, Moseholm E, Norlov AB, Wilken-Jensen C, et al
    Cervical cancer screening integrated in routine clinical care of women living with HIV.
    AIDS. 2024 Jun 28. doi: 10.1097/QAD.0000000000003972.
    PubMed    
    Abstract available

  104. SHI M, Zhang Y
    Efficacy of nimotuzumab in combination with immunotherapy for a young recurrent cervical cancer patient: a case report and literature review.
    Anticancer Drugs. 2024 May 20. doi: 10.1097/CAD.0000000000001611.
    PubMed    
    Abstract available

  105. KHOKHAR M, Kartha P, Hassan S, Pandey RK, et al
    Decoding dysregulated genes, molecular pathways and microRNAs involved in cervical cancer.
    J Gene Med. 2024;26:e3713.
    PubMed    
    Abstract available

  106. SONG LM, Yao DJ, Xia L, Wang XM, et al
    DSG2 and c-MYC Interact to Regulate the Expression of ADAM17 and Promote the Development of Cervical Cancer.
    Cancer Manag Res. 2024;16:703-710.
    PubMed    
    Abstract available

  107. LIU Y, Liu Y, Wang Y, Wang Q, et al
    LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis.
    Oncol Res. 2024;32:1221-1229.
    PubMed    
    Abstract available

  108. JIANG CZ, Zheng K, Zhang YY, Yang J, et al
    (18)F-FDG PET/CT semi-quantitative parameters combined with SCC-Ag in predicting lymph node metastasis in stage I-II cervical cancer.
    Front Oncol. 2024;14:1278464.
    PubMed    
    Abstract available

  109. AFTAB T, Khyzer E, Suhail N, Abdullah Alanzy H, et al
    Knowledge About Cervical Cancer and Awareness About Human Papillomavirus Vaccination Among Medical Students at the Northern Border University, Arar, Kingdom of Saudi Arabia.
    Cureus. 2024;16:e61313.
    PubMed    
    Abstract available

  110. BALAN L, Rusu EL, Ciurescu S, Larisa TV, et al
    Feasibility and Diagnostic Accuracy of Ultrastaging in the Detection of Micrometastases in Sentinel and Non-sentinel Lymph Nodes in Cervical Cancer: A Single-Center Retrospective Study With a Five-Year Follow-Up Period.
    Cureus. 2024;16:e61336.
    PubMed    
    Abstract available

  111. YUAN L, Wang Y, Yu M, Feng Z, et al
    Oncogenic HPV-induced high expression of ESM1 predicts poor prognosis and regulates aerobic glycolysis in cervical cancer.
    iScience. 2024;27:110112.
    PubMed    
    Abstract available

  112. ALARID-ESCUDERO F, Gracia V, Wolf M, Zhao R, et al
    State-level disparities in cervical cancer prevention and impact on outcomes in the U.S.: A modeling study.
    medRxiv [Preprint]. 2024 Jun 12:2024.06.11.24308795.
    PubMed    
    Abstract available

  113. KULAEVA ED, Muzlaeva ES, Mashkina EV
    mRNA-lncRNA gene expression signature in HPV-associated neoplasia and cervical cancer.
    Vavilovskii Zhurnal Genet Selektsii. 2024;28:342-350.
    PubMed    
    Abstract available

  114. MISZCZYK M, Wu T, Kuna K, Stankiewicz M, et al
    Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials.
    Clin Transl Radiat Oncol. 2024;47:100801.
    PubMed    
    Abstract available

  115. WASSIE M, Zegeye AF, Mekonen EG, Tekeba B, et al
    Human papillomavirus vaccination coverage among young women in the three sub-Saharan African countries using Demographic and Health Surveys data.
    Hum Vaccin Immunother. 2024;20:2370111.
    PubMed    
    Abstract available

  116. JOMAH A, Albokhary A
    The impact of the human papillomavirus vaccine on women's health: a systematic review.
    Eur Rev Med Pharmacol Sci. 2024;28:3871-3879.
    PubMed    
    Abstract available

  117. LIU ZL, Chen N, Li R, Ma YJ, et al
    WGCNA reveals a biomarker for cancer-associated fibroblasts to predict prognosis in cervical cancer.
    J Chin Med Assoc. 2024 Jul 1. doi: 10.1097/JCMA.0000000000001129.
    PubMed    
    Abstract available

  118. SUPRIYA Y, Sivamalar S, Nallusamy D, Sureka V, et al
    Application of Probiotics in Cervical Cancer Infections to Enhance the Immune Response.
    Microb Pathog. 2024 Jun 27:106764. doi: 10.1016/j.micpath.2024.106764.
    PubMed    
    Abstract available

  119. PEREIRA D, Alves N, Sousa A, Valente JFA, et al
    Metal-based approaches to fight cervical cancer.
    Drug Discov Today. 2024 Jun 27:104073. doi: 10.1016/j.drudis.2024.104073.
    PubMed    
    Abstract available

  120. MULCAHY SYMMONS S, Drury A, De Brun A
    Stakeholder perceptions of cervical screening accessibility and attendance in Ireland: a qualitative study.
    Health Promot Int. 2024;39:daae072.
    PubMed    
    Abstract available

  121. CHEN Y, Li L, Shi Y, Rong X, et al
    Evaluating the effectiveness of early urethral catheter removal combined with intermittent catheterization for promoting early recovery of bladder function after laparoscopic radical hysterectomy: a study protocol for a randomized controlled trial.
    Trials. 2024;25:422.
    PubMed    
    Abstract available

  122. ZEGEYE FR, Legasu TD, Bayou FD, Ali MA, et al
    Uptake of cervical cancer screening and associated factors among HIV positive women attending adult art clinic at public hospitals in Addis Ababa, Ethiopia, 2022.
    BMC Womens Health. 2024;24:377.
    PubMed    
    Abstract available

  123. NAGAO A, Murakami N, Sakuramachi M, Kashihara T, et al
    Role of the gel spacer in safely delivering whole pelvic radiation therapy without central shielding in computed tomography-based image-guided adaptive brachytherapy for uterine cervical cancer patients.
    Brachytherapy. 2024 Jun 27:S1538-4721(24)00075.
    PubMed    
    Abstract available

  124. XU H, Dong C, Yu Z, Ozaki Y, et al
    Detection and analysis of microplastics in tissues and blood of human cervical cancer patients.
    Environ Res. 2024;259:119498.
    PubMed    
    Abstract available


  125. Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus: Erratum.
    J Low Genit Tract Dis. 2024;28:316.
    PubMed    


  126. DAY T, Stuart L, Ius Y, Haqshenas G, et al
    Fanconi Anemia Complicated by Cervical Precancer, Vulvar, and Oral Squamous Cell Cancer.
    J Low Genit Tract Dis. 2024;28:310-313.
    PubMed    


  127. ENGELBRECHT K, Ovcinnikova O, Ntais D, Shoel H, et al
    Productivity costs due to human papillomavirus-related cancer mortality in the United Kingdom.
    J Med Econ. 2024;27.
    PubMed    
    Abstract available

  128. SCHOLES-ROBERTSON N, Barday Z, Davidson B, Krishnan A, et al
    Access to Cancer Care: Prevention and Screening for Females Post Kidney Transplantation Around the World.
    Semin Nephrol. 2024;44:151502.
    PubMed    
    Abstract available

  129. GOTTSCHLICH A, Hong Q, Gondara L, Alam MS, et al
    Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024;33:904-911.
    PubMed    
    Abstract available

  130. FURUGORI K, Suzuki H, Abe R, Horiuchi K, et al
    Chimera RNA transcribed from integrated HPV18 genome with adjacent host genomic region promotes oncogenic gene expression through condensate formation.
    Genes Cells. 2024;29:532-548.
    PubMed    
    Abstract available

  131. AQUILINA A, Papagiannakis E
    Deep Learning Diagnostic Classification of Cervical Images to Augment Colposcopic Impression.
    J Low Genit Tract Dis. 2024;28:224-230.
    PubMed    
    Abstract available

  132. WEI X, Zhou YH, Chen P
    Distribution and Severity of Cervical Intraepithelial Neoplasia in Women With Different Human Papillomavirus: An Analysis From Liaoning Province of Northeastern China.
    J Low Genit Tract Dis. 2024;28:231-239.
    PubMed    
    Abstract available

  133. TAN CY, Li TT, Xu N, Guo HH, et al
    Mesonephric adenocarcinoma of the cervix: An analysis for 3 cases and literature review.
    Asian J Surg. 2024;47:3233-3234.
    PubMed    


  134. GOPALANI SV, Saraiya M, Huang B, Tucker TC, et al
    Population-level incidence of HPV-positive oropharyngeal, cervical, and anal cancers by smoking status.
    J Natl Cancer Inst. 2024 Mar 1:djae054. doi: 10.1093.
    PubMed    
    Abstract available

  135. KRANKOWSKA D, Mazzitelli M, Ucak HA, Orviz E, et al
    Screening and prevention of HPV-related anogenital cancers in women living with HIV in Europe: Results from a systematic review.
    HIV Med. 2024 Jan 18. doi: 10.1111/hiv.13602.
    PubMed    
    Abstract available

  136. TAGLIAFERRI L, Mancini S, Lancellotta V, Dinapoli L, et al
    The Impact of HAPPY (Humanity Assurance Protocol in Interventional Radiotherapy) on the Psychological Well-being of Gynecological Cancer Patients.
    Curr Radiopharm. 2024;17:168-173.
    PubMed    
    Abstract available

  137. FACHARZTMAGAZINE R
    [Not Available].
    MMW Fortschr Med. 2024;166:66.
    PubMed    


  138. YANG L, Hu H, Yang X, Yan Z, et al
    Whole-tumor histogram analysis of multiple non-Gaussian diffusion models at high b values for assessing cervical cancer.
    Abdom Radiol (NY). 2024 Jul 12. doi: 10.1007/s00261-024-04486.
    PubMed    
    Abstract available

  139. ENDO Y, Soeda S, Yoshimoto Y, Todate Y, et al
    Successful management of locally advanced cervical cancer via total pelvic exenteration following neoadjuvant chemotherapy.
    J Surg Case Rep. 2024;2024:rjae452.
    PubMed    
    Abstract available

  140. GONG X, Xu J, He Y, Zou G, et al
    Socioeconomic inequalities in human papillomavirus knowledge and vaccine uptake: evidence from a cross-sectional study in China.
    Front Public Health. 2024;12:1399192.
    PubMed    
    Abstract available

  141. DATIR SG, Jaiswal A
    Cervical Cancer and Its Association With Pregnancy.
    Cureus. 2024;16:e62144.
    PubMed    
    Abstract available

  142. ZHAO X, Liu Y, Niu J, Shi Y, et al
    A phase III randomized clinical trial comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer.
    Trials. 2024;25:471.
    PubMed    
    Abstract available

  143. QIU S, Wang Q, Jiang H, Feng L, et al
    Immunohistochemistry staining of Eag1 and p16/Ki-67 can help improve the management of patients with cervical intraepithelial Neoplasia after cold knife conversion.
    Diagn Pathol. 2024;19:97.
    PubMed    
    Abstract available

  144. HU J, Wang S, Zhang X, Yan W, et al
    A genetic variant in the TAPBP gene enhances cervical cancer susceptibility by increasing m(6)A modification.
    Arch Toxicol. 2024 Jul 12. doi: 10.1007/s00204-024-03820.
    PubMed    
    Abstract available

  145. WANG K, Qu A, Deng X, Jiang W, et al
    Efficacy and safety of 3-dimensional printing noncoplanar template (3D-PNCT)-assisted high-dose-rate interstitial brachytherapy (HDR-ISBT) for reirradiation of recurrent cervical cancer: a prospective cohort.
    J Gynecol Oncol. 2024 Jul 4. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  146. CAO Y, Peng Y, Tang Y
    ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis.
    J Gynecol Oncol. 2024 Jul 2. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  147. CUI Y, Zhao Y, Shen G, Lv Q, et al
    CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcription.
    Transl Oncol. 2024;47:102038.
    PubMed    
    Abstract available

  148. ZHONG S, Ai C, Ding Y, Tan J, et al
    Combining multimodal diffusion-weighted imaging and morphological parameters for detecting lymph node metastasis in cervical cancer.
    Abdom Radiol (NY). 2024 Jul 11. doi: 10.1007/s00261-024-04494.
    PubMed    
    Abstract available

  149. HSU CD, Yu X, Guo F, Adekanmbi V, et al
    Cervical cancer screening utilization among kidney transplant recipients, 2001-2018.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed    
    Abstract available

  150. MENG X, Gao B, Li N
    Mitochondrial protein isoleucyl-tRNA synthetase 2 in tumor cells as a potential therapeutic target for cervical cancer.
    Cytojournal. 2024;21:22.
    PubMed    
    Abstract available

  151. NODA T, Fukuda T, Uchikura E, Awazu Y, et al
    Predicting recurrence in intermediate? and high?risk stage IB?IIB cervical cancer treated with adjuvant cisplatin and paclitaxel chemotherapy post?radical hysterectomy: The role of TBX2 expression.
    Oncol Lett. 2024;28:414.
    PubMed    
    Abstract available

  152. WU M, Zhou JL, Zhang Z, Meng YG, et al
    Identifying Comprehensive Genomic Alterations and Potential Neoantigens for Cervical Cancer Immunotherapy in a Cohort of Chinese Squamous Cell Carcinoma of the Cervix.
    Biomed Environ Sci. 2024;37:565-580.
    PubMed    
    Abstract available

  153. PATTERSON MR, Cogan JA, Cassidy R, Theobald DA, et al
    The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer.
    Nat Commun. 2024;15:5809.
    PubMed    
    Abstract available

  154. LIBERACKA-DWOJAK M, Wilkosc-Debczynska M, Perkowski R
    Breaking the silence: the role of sexual communication on quality of life in women with cervical cancer.
    Support Care Cancer. 2024;32:503.
    PubMed    
    Abstract available

  155. SARWAR F, Ashhad S, Vimal A, Vishvakarma R, et al
    Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer.
    Med Oncol. 2024;41:199.
    PubMed    
    Abstract available

  156. SANTOS BMD, Araujo Junior E, Zanine RM
    Is the colposcopic lesion size a predictor of high-grade lesions in young patients?
    Einstein (Sao Paulo). 2024;22:eAO0462.
    PubMed    
    Abstract available

  157. GOKCAY G, Akar N, Bagis KO, Ugurlu A, et al
    The relationship between individuals' knowledge of human papillomavirus, attitudes towards HPV vaccination, and vaccine hesitancy: A cross-sectional study.
    Afr J Reprod Health. 2024;28:103-116.
    PubMed    
    Abstract available

  158. SHEN Y, Jin X, Zhu Y, He C, et al
    Clinical analysis of patients with skin metastasis of cervical squamous cell carcinoma.
    Chin Clin Oncol. 2024;13:35.
    PubMed    
    Abstract available

  159. WANG R, Huang H, Yu C, Li X, et al
    Current status and future directions for the development of human papillomavirus vaccines.
    Front Immunol. 2024;15:1362770.
    PubMed    
    Abstract available

  160. FANG J, Wang Y, Li C, Liu W, et al
    A hypoxia-derived gene signature to suggest cisplatin-based therapeutic responses in patients with cervical cancer.
    Comput Struct Biotechnol J. 2024;23:2565-2579.
    PubMed    
    Abstract available

  161. RAMPHUL R, Zamorano AS, Upadhyay S, Desai M, et al
    Spatiotemporal analysis of HPV vaccination and associated neighborhood-level disparities in Texas-an ecological study.
    Front Public Health. 2024;12:1418526.
    PubMed    
    Abstract available

  162. KORALAHALLI KP, Hussain S, D DW, Siddikuzzaman, et al
    Molecular Actions of Enicostemma hyssopifolium Whole Plant Extract on HPV18-Infected Human Cervical Cancer (HeLa) Cells.
    Anticancer Agents Med Chem. 2024.
    PubMed    
    Abstract available

  163. RASMUSSEN PW, Hoffman RM, Phiri S, Makwaya A, et al
    Cost-effectiveness of approaches to cervical cancer screening in Malawi: comparison of frequencies, lesion treatment techniques, and risk-stratified approaches.
    BMC Health Serv Res. 2024;24:792.
    PubMed    
    Abstract available

  164. STUART RM, Cohen JA, Abeysuriya RG, Sanz-Leon P, et al
    Inferring the natural history of HPV from global cancer registries: insights from a multi-country calibration.
    Sci Rep. 2024;14:15875.
    PubMed    
    Abstract available

  165. ALMEIDA TAG, Dos Santos OP, Saddi VA, Pereira JX, et al
    Association of CD133, ALDH1, CD117 and OCT4 expression with prognosis of patients with cervical cancer.
    Virchows Arch. 2024 Jul 9. doi: 10.1007/s00428-024-03862.
    PubMed    
    Abstract available

  166. TAY SK
    Improving the effectiveness of cervical cancer screening: Managing positive high-risk human papillomavirus results.
    Ann Acad Med Singap. 2024;53:342-351.
    PubMed    
    Abstract available

  167. CHIN FHX
    Evaluating the effectiveness of cervical cancer screening and prevention in Singapore.
    Ann Acad Med Singap. 2024;53:338-339.
    PubMed    


  168. ASANGBEH-KERMAN SL, Davidovic M, Taghavi K, Dhokotera T, et al
    Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based survey.
    J Int AIDS Soc. 2024;27:e26303.
    PubMed    
    Abstract available

  169. GAO Y, Wang H, Jiang M
    Comparative effectiveness of neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stages IB2 to IIB of cervical cancer: a meta-analysis.
    Front Oncol. 2024;14:1426002.
    PubMed    
    Abstract available

  170. YANG H, Chen Z, Lou H, Ying W, et al
    Effects of Sintilimab Plus Radiotherapy on Levels of Spondin-2 and Glucose Transporter-1 in Patients with Cervical Cancer.
    Int J Gen Med. 2024;17:2931-2937.
    PubMed    
    Abstract available

  171. ZHAO F, Yan H, Liu Y, Mu X, et al
    Knowledge, attitudes and practices toward cervical cancer screening among ethnic minorities in inner Mongolia, China.
    J Eval Clin Pract. 2024 Jul 8. doi: 10.1111/jep.14074.
    PubMed    
    Abstract available

  172. HAN F, Xue Y, Huang S, Lu T, et al
    Development and validation of an automated Tomotherapy planning method for cervical cancer.
    Radiat Oncol. 2024;19:88.
    PubMed    
    Abstract available

  173. AGABA CD, Namuli A, Ainomugisha B, Tibaijuka L, et al
    Providers and women's perspectives on opportunities, challenges and recommendations to improve cervical cancer screening in women living with HIV at Mbarara Regional Referral Hospital: a qualitative study.
    BMC Womens Health. 2024;24:392.
    PubMed    
    Abstract available

  174. NAMALINZI F, Galadima KR, Nalwanga R, Sekitoleko I, et al
    Prediction of precancerous cervical cancer lesions among women living with HIV on antiretroviral therapy in Uganda: a comparison of supervised machine learning algorithms.
    BMC Womens Health. 2024;24:393.
    PubMed    
    Abstract available

  175. LI J, Qi J, Zhang J, Zhang Y, et al
    Relationships between nine neuropsychiatric disorders and cervical cancer: insights from genetics, causality and shared gene expression patterns.
    BMC Womens Health. 2024;24:394.
    PubMed    
    Abstract available

  176. AJAKAIYE A, Watson D, Abdelsalam H, Alalade A, et al
    Extranodal diffuse large B-cell lymphoma involving the uterine cervix.
    BMJ Case Rep. 2024;17:e244315.
    PubMed    
    Abstract available

  177. GEZELS E, Van Roy K, Arbyn M, Coursier P, et al
    The ESSAG-trial protocol: A randomized controlled trial evaluating the efficacy of offering a self-sampling kit by the GP to reach women underscreened in the routine cervical cancer screening program.
    Contemp Clin Trials. 2024 Jul 6:107617. doi: 10.1016/j.cct.2024.107617.
    PubMed    
    Abstract available

  178. LIN X, Zhan J, Guan Z, Zhang J, et al
    Clinicopathologic and prognostic significance of tumor-associated macrophages in cervical cancer: a systematic review and meta-analysis.
    Clin Transl Oncol. 2024 Jul 8. doi: 10.1007/s12094-024-03587.
    PubMed    
    Abstract available

  179. JIA Y, Li Y, Du N, Zhao W, et al
    LIMK1 promotes the development of cervical cancer by up-regulating the ROS/Src-FAK/cofilin signaling pathway.
    Aging (Albany NY). 2024;16.
    PubMed    
    Abstract available

  180. ORINGTHO S, Mwaka AD, Garimoi Orach C, Wabinga H, et al
    Awareness of cervical cancer risk factors and preventive approaches, and perceived causes of cervical cancer among secondary school girls: a cross-sectional study in Northern Uganda.
    Ann Med. 2024;56:2374860.
    PubMed    
    Abstract available

  181. SEBI EP, Tejanaik P, Narendiran V
    Healthcare Provider-Related Factors in the Diagnostic Delay of Cervical Cancer: A Cross-Sectional Study.
    Cureus. 2024;16:e61865.
    PubMed    
    Abstract available

  182. DIOP A, Mvundura M, Dieng Y, Anne M, et al
    Cervical cancer screening and treatment costing in Senegal.
    Pan Afr Med J. 2024;47:151.
    PubMed    
    Abstract available

  183. ALMONTE M, Ilbawi AM, Maza M, Saville M, et al
    From commitments to action: the first global cervical cancer elimination forum.
    Lancet Reg Health Am. 2024;36:100812.
    PubMed    


  184. AVINU ES, Kutah J, Akumiah PO, Opoku-Addai K, et al
    Knowledge, perception and cervical cancer screening practices among nurses and midwives: a case study of Our Lady of Grace Hospital in the Asikuma Odoben Brakwa district, Central region-Ghana.
    Afr Health Sci. 2023;23:487-497.
    PubMed    
    Abstract available

  185. KUPAS D, Hajdu A, Kovacs I, Hargitai Z, et al
    Annotated Pap cell images and smear slices for cell classification.
    Sci Data. 2024;11:743.
    PubMed    
    Abstract available

  186. ZHANG Y, Li H, Wei Y, Li L, et al
    Alantolactone Induced Apoptosis and DNA Damage of Cervical Cancer through ATM/CHK2 Signaling Pathway.
    Biol Pharm Bull. 2024;47:1255-1264.
    PubMed    
    Abstract available

  187. BOAKYE EA, Gerend MA, Nair M, Khan HY, et al
    Trends in awareness of the causal link between HPV and cervical cancer in the US: 2013 to 2022.
    Am J Prev Med. 2024 Jul 5:S0749-3797(24)00225.
    PubMed    


  188. CARVALHO MFL, Calicchio CS, de Almeida BO, de Miranda LBL, et al
    Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells.
    Clinics (Sao Paulo). 2024;79:100422.
    PubMed    
    Abstract available

  189. HARANGI B, Bogacsovics G, Toth J, Kovacs I, et al
    Pixel-wise segmentation of cells in digitized Pap smear images.
    Sci Data. 2024;11:733.
    PubMed    
    Abstract available

  190. WESCHASAT T, Wetchasat N, Chuemchit M
    The edutainment program on knowledge, perception, and uptake of cervical cancer screening among Muslim women in Southern Thailand: a quasi experimental study.
    BMC Public Health. 2024;24:1803.
    PubMed    
    Abstract available

  191. TRESSERRA F, Fabra G, Luque O, Castella M, et al
    Validation of digital image slides for diagnosis in cervico-vaginal cytology.
    Rev Esp Patol. 2024;57:182-189.
    PubMed    
    Abstract available

  192. FORTEZA A, Vanrell C, Matheu G, Cortes J, et al
    Validation of immunohistochemical overexpression of p16 in the histologic diagnosis of cervical intraepithelial neoplasia grade 2.
    Rev Esp Patol. 2024;57:169-175.
    PubMed    
    Abstract available

  193. YU M, Ni M, Xu F, Liu C, et al
    NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer.
    Mol Cancer. 2024;23:139.
    PubMed    
    Abstract available

  194. GUO F, Kong W, Li D, Zhao G, et al
    M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway.
    Eur J Med Res. 2024;29:357.
    PubMed    
    Abstract available

  195. LIU FH, Zhao XR, Zhang XL, Zhao M, et al
    Multiparametric mri-based radiomics nomogram for predicting lymph-vascular space invasion in cervical cancer.
    BMC Med Imaging. 2024;24:167.
    PubMed    
    Abstract available

  196. BEILANKOUHI EAV, Maghsoodi MS, Sani MZ, Khosroshahi NS, et al
    miRNAs that regulate apoptosis in breast cancer and cervical cancer.
    Cell Biochem Biophys. 2024 Jul 6. doi: 10.1007/s12013-024-01405.
    PubMed    
    Abstract available

  197. ZHANG K, Zhang Y, Wu H, Wu S, et al
    ASO Visual Abstract: Complete Laparoscopic Type C2 Radical Surgery for Cervical Stump Cancer-No-Look and No-Touch Techniques.
    Ann Surg Oncol. 2024;31:5320-5321.
    PubMed    


  198. MOORE LC, Ahern F, Li L, Kallis K, et al
    Neural network dose prediction for cervical brachytherapy: Overcoming data scarcity for applicator-specific models.
    Med Phys. 2024;51:4591-4606.
    PubMed    
    Abstract available

  199. LUO WX, Ding XM, Cheng JM, Liu X, et al
    Nomogram based on MRI and clinical features to predict progression-free survival in patients with stage IIIC1r cervical squamous cell carcinoma: A two-center study.
    Clin Radiol. 2024;79:e1031-e1039.
    PubMed    
    Abstract available

  200. ZHANG K, Zhang Y, Wu H, Wu S, et al
    Complete Laparoscopic Type C2 Radical Surgery for Cervical Stump Cancer: No-Look and No-Touch Techniques.
    Ann Surg Oncol. 2024;31:5111-5114.
    PubMed    
    Abstract available

  201. YAGI A, Ueda Y, Oka E, Nakagawa S, et al
    Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered.
    Cancer Sci. 2024;115:2410-2416.
    PubMed    
    Abstract available

  202. SAKATA M, Mabuchi S, Maeda M, Nagata S, et al
    Extraovarian seromucinous borderline tumor: Case report and literature review.
    J Obstet Gynaecol Res. 2024;50:1263-1267.
    PubMed    
    Abstract available

  203. GU Y, Chu C, Yuan B, Wang J, et al
    Expression and hypermethylation of JAM and EPB41L3 in cervical squamous cell carcinoma: Clinical significance and applications.
    Histol Histopathol. 2024;39:1043-1051.
    PubMed    
    Abstract available

  204. SISIN NNT, Kong AR, Edinur HA, Jamil NIN, et al
    Silencing E6/E7 Oncoproteins in SiHa Cells Treated with siRNAs and Oroxylum indicum Extracts Induced Apoptosis by Upregulating p53/pRb Pathways.
    Appl Biochem Biotechnol. 2024;196:4234-4255.
    PubMed    
    Abstract available

  205. JINDAKAN S, Tharavichitkul E, Watcharawipha A, Nobnop W, et al
    Improvement of treatment plan quality with modified fixed field volumetric modulated arc therapy in cervical cancer.
    J Appl Clin Med Phys. 2024 Jul 20:e14479. doi: 10.1002/acm2.14479.
    PubMed    
    Abstract available

  206. KARTHIKA J, Anantharaju A, Koodi D, Pandya HJ, et al
    Label-free assessment of the transformation zone using multispectral diffuse optical imaging toward early detection of cervical cancer.
    J Biophotonics. 2024 Jul 20:e202400114. doi: 10.1002/jbio.202400114.
    PubMed    
    Abstract available

  207. NARTEY Y, Amo-Antwi K, Hill PC, Dassah ET, et al
    Risk Factors for Cervical Cancer in Ghana.
    Cancer Rep (Hoboken). 2024;7:e2124.
    PubMed    
    Abstract available

  208. TISHE ZH, Shawkat S, Popy MN, Mumu SB, et al
    Cervical cancer risk in association with TNF-alpha gene polymorphisms in Bangladeshi women.
    Tumour Biol. 2024;46:13-24.
    PubMed    
    Abstract available

  209. NOOR MOHAMAD NA, Omar J
    Cervical cancer in Malaysia.
    J Obstet Gynaecol Res. 2024 Jul 19. doi: 10.1111/jog.16031.
    PubMed    
    Abstract available

  210. KAMATA M, Fusegi A, Kurihara N, Abe A, et al
    Effects of tumor spillage prevention in laparoscopic radical hysterectomy for early-stage cervical cancer: a propensity score-matched analysis.
    J Gynecol Oncol. 2024 Jul 12. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  211. JI C, Liu S, Wang C, Chen J, et al
    Relationship between visceral obesity and prognosis in patients with stage IVB cervical cancer receiving radiotherapy and chemotherapy.
    Cancer Pathog Ther. 2023;2:180-186.
    PubMed    
    Abstract available

  212. WU L, Li S, Li S, Lin Y, et al
    Preoperative magnetic resonance imaging-radiomics in cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1416378.
    PubMed    
    Abstract available

  213. DENECKE A, Emar D, Hillemanns P, Ramachandran D, et al
    Diagnostic cervical excision in patients with HPV positivity, cytological abnormalities- and preoperative cervical stenosis.
    BMC Womens Health. 2024;24:411.
    PubMed    
    Abstract available

  214. HE C, Zhang J, Bai X, Lu C, et al
    Lysine lactylation-based insight to understanding the characterization of cervical cancer.
    Biochim Biophys Acta Mol Basis Dis. 2024 Jul 16:167356.
    PubMed    
    Abstract available

  215. PENG Q, Deng Y, Li G, Li J, et al
    Quantitative Proteomics Reveal the Mechanism of MiR-138-5p Suppressing Cervical Cancer via Targeting ZNF385A.
    J Proteome Res. 2024 Jul 18. doi: 10.1021/acs.jproteome.4c00349.
    PubMed    
    Abstract available

  216. NNADI EN, Khatun N, John S
    A Rare Encounter With Unusual Metastasis: Metastatic Right Ventricular Tumor Secondary to Cervical Cancer.
    Cureus. 2024;16:e62530.
    PubMed    
    Abstract available

  217. WANG X, Feng C, Huang M, Liu S, et al
    Cervical cancer segmentation based on medical images: a literature review.
    Quant Imaging Med Surg. 2024;14:5176-5204.
    PubMed    
    Abstract available

  218. LI S, Gao K, Yao D
    Comprehensive Analysis of angiogenesis associated genes and tumor microenvironment infiltration characterization in cervical cancer.
    Heliyon. 2024;10:e33277.
    PubMed    
    Abstract available

  219. GU Y, Mu Q, Cheng D
    Androgens in cervical cancer: Their role in epidemiology and biology.
    iScience. 2024;27:110155.
    PubMed    
    Abstract available

  220. RASHEED FA, Yakasai IA, Abdurrahman A, Usman A, et al
    Human papillomavirus serotypes and determinants among women with invasive cervical cancer in Katsina state, Northwest-Nigeria: a multicentre study.
    Ecancermedicalscience. 2024;18:1714.
    PubMed    
    Abstract available

  221. ONYANGO OE, Masinde D, Ouma C
    Improving cervical cancer screening rates among women of reproductive age in rural Kisumu County through dialogue-based community health education.
    Ecancermedicalscience. 2024;18:1713.
    PubMed    
    Abstract available

  222. LIM L, Slee A, Lim PC
    Feasibility and early oncologic outcomes of Total Intracorporeal Robotic Radical Hysterectomy with Vaginal Cerclage (TIRRHVC) for the treatment of clinical stage IB cervical cancer: A tumor containment technique.
    Gynecol Oncol Rep. 2024;54:101437.
    PubMed    
    Abstract available

  223. EZZELARAB S, El-Husseiny A, Nasreldin M, Ali R, et al
    Cervical cancer screening by cytology and the burden of epithelial abnormalities in low resource settings: a tertiary-center 42-year study.
    BMC Womens Health. 2024;24:405.
    PubMed    
    Abstract available

  224. HU J, Liu G, Liu Y, Yuan M, et al
    Predicting lower limb lymphedema after cervical cancer surgery using artificial neural network and decision tree models.
    Eur J Oncol Nurs. 2024;72:102650.
    PubMed    
    Abstract available

  225. KUNTAMUNG K, Sangthong P, Jakmunee J, Ounnunkad K, et al
    Simultaneous immunodetection of multiple cervical cancer biomarkers based on a signal-amplifying redox probes/polyethyleneimine-coated gold nanoparticles/2D tungsten disulfide/graphene oxide nanocomposite platform.
    Bioelectrochemistry. 2024;160:108780.
    PubMed    
    Abstract available

  226. ZHU Z, Nie X, Deng L, Ding J, et al
    Regulation of cervical cancer via G15-mediated inhibition of G protein-coupled estrogen receptor.
    Anticancer Drugs. 2024 Jul 17. doi: 10.1097/CAD.0000000000001640.
    PubMed    
    Abstract available

  227. BASHAR MA, Khan IA
    Introduction of HPV vaccine in universal immunization programme of India: A step in the right direction for the elimination of cervical cancer.
    Indian J Cancer. 2024 Jul 13. doi: 10.4103.
    PubMed    


  228. LI J, Zhang X, Yang L, Zhu Y, et al
    Corrigendum: Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer.
    Front Immunol. 2024;15:1437676.
    PubMed    
    Abstract available

  229. MWENDA V, Murage D, Kilonzo C, Bor JP, et al
    Baseline assessment of cervical cancer screening and treatment capacity in 25 counties in Kenya, 2022.
    Front Oncol. 2024;14:1371529.
    PubMed    
    Abstract available

  230. CHI C, Tang X, Liu W, Zhou Y, et al
    Exosomal lncRNA USP30-AS1 activates the Wnt/beta-catenin signaling pathway to promote cervical cancer progression via stabilization of beta-catenin by USP30.
    Biotechnol J. 2024;19:e2300653.
    PubMed    
    Abstract available

  231. NAKAMURA K, Kigure K, Nishimura T, Yamashita S, et al
    Questionnaire survey on cervical cancer screening and HPV awareness among patients at a local cancer center in Japan.
    BMC Womens Health. 2024;24:402.
    PubMed    
    Abstract available

  232. HU X, Wang W, Ma T, Zhang W, et al
    Long non-coding RNA SIX1-1 promotes proliferation of cervical cancer cells via negative transcriptional regulation of RASD1.
    Hum Cell. 2024 Jul 16. doi: 10.1007/s13577-024-01104.
    PubMed    
    Abstract available

  233. WANG F, Yue S, Huang Q, Lei T, et al
    Cellular heterogeneity and key subsets of tissue-resident memory T cells in cervical cancer.
    NPJ Precis Oncol. 2024;8:145.
    PubMed    
    Abstract available

  234. KOUR S, Biswas I, Sheoran S, Arora S, et al
    Betulin: a novel triterpenoid anti-cancerous agent targeting cervical cancer through epigenetic proteins.
    Mol Divers. 2024 Jul 16. doi: 10.1007/s11030-024-10930.
    PubMed    
    Abstract available

  235. OWARE J, Iddrisu M, Konlan KD, Dzansi G, et al
    Challenges and support systems of nurses caring for women with advanced cervical cancer in Accra, Ghana.
    BMC Palliat Care. 2024;23:174.
    PubMed    
    Abstract available

  236. THAREJA G, Salvioni A, Lauzeral-Vizcaino F, Halabi N, et al
    Assessing the implications of sentinel lymph node removal in cervical cancer: an immunogenetic perspective - a SENTICOL ancillary study.
    J Immunother Cancer. 2024;12:e008734.
    PubMed    
    Abstract available

  237. ALONSO-ESPIAS M, Gracia M, Zapardiel I
    Benefits of sentinel node detection in cervical cancer.
    Curr Opin Oncol. 2024 Jun 13. doi: 10.1097/CCO.0000000000001063.
    PubMed    
    Abstract available

  238. SCHINDLER S, Netto E, Deminco F, Figueiredo CA, et al
    Detection of cytokines in cervicovaginal lavage in HIV-infected women and its association with high-risk human papillomavirus.
    Front Immunol. 2024;15:1416204.
    PubMed    
    Abstract available

  239. ARANGO-BRAVO EA, Galicia-Carmona T, Cetina-Perez L, Flores-de la Torre CB, et al
    State of the art of cervical cancer treatment in rare histologies.
    Front Oncol. 2024;14:1386294.
    PubMed    
    Abstract available

  240. FALCONER H, Norberg-Hardie A, Salehi S, Alfonzo E, et al
    Oncologic outcomes after Total Mesometrial Resection (TMMR) or treatment according to current international guidelines in FIGO (2009) stages IB1-IIB cervical cancer: an observational cohort study.
    EClinicalMedicine. 2024;73:102696.
    PubMed    
    Abstract available

  241. WANG W, Yao S, Jiang H, Dong J, et al
    [Retracted] Upstream transcription factor 1 prompts malignancies of cervical cancer primarily by transcriptionally activating p65 expression.
    Exp Ther Med. 2024;28:342.
    PubMed    
    Abstract available

  242. LAGU IJL, Nyamai DW, Njeru SN
    Phytochemical analysis, in-vitro and in-silico study of antiproliferative activity of ethyl acetate fraction of Launaea cornuta (Hochst. ex Oliv. & Hiern) C. Jeffrey against human cervical cancer cell line.
    Front Pharmacol. 2024;15:1399885.
    PubMed    
    Abstract available

  243. HAN GH, Kim HR, Yun H, Chung JY, et al
    Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning.
    Am J Cancer Res. 2024;14:3186-3197.
    PubMed    
    Abstract available

  244. WEI LJ, Fu J, Yang HX, Yang X, et al
    Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer.
    J Transl Med. 2024;22:655.
    PubMed    
    Abstract available

  245. DULL PM, Achilles SL, Ahmed R, Barnabas RV, et al
    Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.
    Vaccine. 2024 Jul 13:S0264-410X(24)00741-2. doi: 10.1016/j.vaccine.2024.
    PubMed    
    Abstract available

  246. SINGH P, Gothwal M, Yadav G
    Dual-staining with P16 and Ki67 in the triaging of ASC-US and the LSIL group beneficial or added financial burden, still a diagnostic dilemma.
    Taiwan J Obstet Gynecol. 2024;63:593.
    PubMed    


  247. SRISUTTAYASATHIEN M, Kantathavorn N, Luasiripanthu T, Petchjorm S, et al
    Response to "Is it practical to add the p16/Ki67 immunohistochemical dual staining into liquid-based cytology for cervical cancer screening?".
    Taiwan J Obstet Gynecol. 2024;63:592.
    PubMed    


  248. CHIKAZAWA K, Imai K, Kuwata T, Konno R, et al
    What Is the Future of Radical Hysterectomy? Commentary on the Indication for Minimally Invasive Surgery for Cervical Cancer
    J Obstet Gynaecol Can. 2024;46:102242.
    PubMed    


  249. COURBIERE B, Miquel L, Bottin P, Provansal M, et al
    Heterotopic ovarian transplantation instead hormonal replacement therapy after radical hysterectomy for cervical cancer: case report and review of literature.
    J Assist Reprod Genet. 2024 Jul 14. doi: 10.1007/s10815-024-03196.
    PubMed    
    Abstract available

  250. IBRAIMOVA DD, Tilekov EA, Shaimbetov BO, Bekeshova EN, et al
    [The lost years of potential life under cancer of neck of uterus in the Kyrgyz Republic].
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2024;32:462-466.
    PubMed    
    Abstract available

  251. PEREZ-CRUZ E, Howlet-Caballero LC, Villanueva XJ
    Association of albumin, neutrophil-lymphocyte ratio and lymphocytes with clinical stage in cervical cancer patients.
    Clin Transl Oncol. 2024 Jul 13. doi: 10.1007/s12094-024-03575.
    PubMed    
    Abstract available

  252. FLORES CEA, Falang BM, Gomez-Laguna L, Gutierrez GG, et al
    Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico.
    Cancers (Basel). 2024;16:2485.
    PubMed    
    Abstract available

  253. MURAMOTO Y, Murakami N, Okonogi N, Takatsu J, et al
    Dose Contribution to the Regional Lymph-Node Metastases and Point B from Intracavity and Interstitial Hybrid Brachytherapy in Locally Advanced Cervical Cancer.
    Cancers (Basel). 2024;16:2384.
    PubMed    
    Abstract available

  254. LUCIC S, Spirovski M, Stojanovic D, Peter A, et al
    18F-FDG PET/CT- and MRI-Based Locally Advanced Cervical Cancer Early-Response Assessment after Concurrent Chemo- and Radiotherapy-Impact on Patient Outcomes and Survival Prediction.
    Diagnostics (Basel). 2024;14:1432.
    PubMed    
    Abstract available

  255. VALLE-MENDIOLA A, Rocha-Zavaleta L, Maldonado-Lagunas V, Morelos-Laguna D, et al
    STAT5 Is Necessary for the Metabolic Switch Induced by IL-2 in Cervical Cancer Cell Line SiHa.
    Int J Mol Sci. 2024;25:6835.
    PubMed    
    Abstract available

  256. TANAKA T, Nishie R, Murakami H, Tsuchihashi H, et al
    Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node Biopsy.
    J Clin Med. 2024;13:3981.
    PubMed    
    Abstract available

  257. VAN TRAPPEN P, Walgraeve MS, Roels S, Claes N, et al
    Robotic-Assisted Pelvic Exenteration for Cervical Cancer: A Systematic Review and Novel Insights into Compartment-Based Imaging.
    J Clin Med. 2024;13:3673.
    PubMed    
    Abstract available

  258. NINKOVA RV, Calabrese A, Curti F, Riccardi S, et al
    The performance of the node reporting and data system 1.0 (Node-RADS) and DWI-MRI in staging patients with cervical carcinoma according to the new FIGO classification (2018).
    Radiol Med. 2024;129:1062-1075.
    PubMed    
    Abstract available

  259. PORTOCARRERO-BONIFAZ A, Syed S, Kassel M, McKenzie GW, et al
    Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy.
    Brachytherapy. 2024;23:397-406.
    PubMed    
    Abstract available

  260. DING X, Wan A, Qi X, Jiang K, et al
    ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification.
    Curr Gene Ther. 2024;24:441-452.
    PubMed    
    Abstract available

  261. KHAOULA M, Saber Hassine A, Sirine B, Sana M, et al
    Cervix Relapses of Lymphoblastic Leukemia Type B.
    J Obstet Gynaecol Can. 2024;46:102414.
    PubMed    


  262. KUMAR N, Mangla M, Palo S, Gabbeta S, et al
    Stratified Mucin-Producing Intraepithelial Lesion of the Cervix in an HPV-16 Positive Woman: A Rare Encounter.
    Infect Disord Drug Targets. 2024;24:e290124226396.
    PubMed    
    Abstract available

  263. CERNUSCHI T, Hall S, Malvolti S, Bloem P, et al
    Improving access to human papillomavirus vaccines: A case study in the IA2030 core principle of partnership.
    Vaccine. 2022 Dec 7:S0264-410X(22)01453-0. doi: 10.1016/j.vaccine.2022.
    PubMed    
    Abstract available

  264. ZHAO M, Li Z, Gu X, Yang X, et al
    The role of radiomics for predicting of lymph-vascular space invasion in cervical cancer patients based on artificial intelligence: a systematic review and meta-analysis.
    J Gynecol Oncol. 2024 Jul 19. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  265. DEVOTTA K, O'Campo P, Bender J, Lofters AK, et al
    Important and Feasible Actions to Address Cervical Screening Participation amongst South Asian Women in Ontario: A Concept Mapping Study with Service Users and Service Providers.
    Curr Oncol. 2024;31:4038-4051.
    PubMed    
    Abstract available

  266. SCHELZ Z, Muddather HF, Jaski FS, Bozsity N, et al
    An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer.
    Curr Issues Mol Biol. 2024;46:6566-6579.
    PubMed    
    Abstract available

  267. KUGUYO O, Matimba A, Madziyire MG, Magwali T, et al
    Prevalence and predictors for cisplatin-induced toxicities in Zimbabwean women with cervical cancer.
    Future Oncol. 2024 Jul 26:1-16. doi: 10.1080/14796694.2024.2375959.
    PubMed    
    Abstract available


  268. Retraction: MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3.
    Oncol Res. 2024;32:1371.
    PubMed    
    Abstract available

  269. LIN X, Fang Y, Mi X, Fu J, et al
    Asiatic acid inhibits cervical cancer cell proliferation and migration via PI3K/AKT/mTOR signaling pathway.
    Heliyon. 2024;10:e34047.
    PubMed    
    Abstract available

  270. LEE SY, Oh TJ, An S, Lee SH, et al
    Overexpression of Hypermethylated Homeobox A11 (HOXA11) Inhibits Tumor Cell Growth and Induces Apoptosis in Cervical Cancer.
    Dev Reprod. 2024;28:37-45.
    PubMed    
    Abstract available

  271. ZHANG X, Zhang X, Chen Y, Ou T, et al
    Epidemiological trends and burden analysis of cervical cancer attributable to unsafe sex: A population-based study from 1990 to 2019.
    Public Health Nurs. 2024 Jul 25. doi: 10.1111/phn.13382.
    PubMed    
    Abstract available

  272. LEE CY, Kim H, Degani I, Lee H, et al
    Empowering the on-site detection of nucleic acids by integrating CRISPR and digital signal processing.
    Nat Commun. 2024;15:6271.
    PubMed    
    Abstract available

  273. ZHU Z, Wang Y, Han J, Li Y, et al
    Associations of Pap test utilisation with comorbidity and functional impairment among middle-aged non-Hispanic black women in the USA: a cross-sectional analysis of the 2018 BRFSS data.
    BMJ Open. 2024;14:e076247.
    PubMed    
    Abstract available

  274. DECKER KM, Musto G, Bucher O, Czaykowski P, et al
    Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.
    Technol Cancer Res Treat. 2024;23:15330338241263616.
    PubMed    
    Abstract available

  275. BIRRER M, Li G, Yunokawa M, Lee JY, et al
    Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure: A Nonrandomized Controlled Trial.
    JAMA Oncol. 2024 Jul 25. doi: 10.1001/jamaoncol.2024.2145.
    PubMed    
    Abstract available

  276. ZHANG Y, Liu T, He W
    The application of organoids in cancers associated with pathogenic infections.
    Clin Exp Med. 2024;24:168.
    PubMed    
    Abstract available

  277. HU W, Fu R
    [Trans-YOLOv5: a YOLOv5-based prior transformer network model for automated detection of abnormal cells or clumps in cervical cytology images].
    Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:1217-1226.
    PubMed    
    Abstract available

  278. XING H, Yuan D, Zhu Y, Jiang L, et al
    A nomogram model based on SII, AFR, and NLR to predict infectious complications of laparoscopic hysterectomy for cervical cancer.
    World J Surg Oncol. 2024;22:190.
    PubMed    
    Abstract available

  279. DAI W, Wang T, Chen L, Qiu Z, et al
    Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study.
    BMC Womens Health. 2024;24:419.
    PubMed    
    Abstract available

  280. INTIMAYTA-ESCALANTE C
    Ethnic inequalities in coverage and use of women's cancer screening in Peru.
    BMC Womens Health. 2024;24:418.
    PubMed    
    Abstract available

  281. ZHANG T, Wang C, Wang K, Liang Y, et al
    Correction: RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK.
    Cell Death Dis. 2024;15:528.
    PubMed    


  282. GENCTURK N, Karaahmet AY, Comert D
    The impact of herbal treatments on cervicovaginal human papillomavirus infection: a systematic review and meta-analysis.
    Rev Assoc Med Bras (1992). 2024;70:e20240141.
    PubMed    
    Abstract available

  283. BENGTSON L, Lynch S
    Trauma, PTSD, and Self-Efficacy: Predictors of Cervical Cancer Screening in Sexual Violence Survivors.
    J Interpers Violence. 2024 Jul 24:8862605241265431.
    PubMed    
    Abstract available

  284. BORNSTEIN J, Sacinti KG, Preti M, Billan S, et al
    Changing the paradigm: Elimination - Not only of cervical cancer.
    Gynecol Oncol Rep. 2024;54:101445.
    PubMed    
    Abstract available

  285. MCGILL F, Fields PJ, Bahadoor-Yetman A, Manglardi ES, et al
    Investigating under-reported human papillomavirus genotypes in Grenadian women through self-sampling for cervical cancer screening.
    Rev Panam Salud Publica. 2024;48:e62.
    PubMed    
    Abstract available

  286. ZUO J, Duan W, Zhao M, Chen Z, et al
    Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial.
    Cancer Commun (Lond). 2024 Jul 23. doi: 10.1002/cac2.12578.
    PubMed    


  287. WIGHT AJ
    Latin America is catching up on HPV vaccination and screening.
    BMJ. 2024;386:q1553.
    PubMed    


  288. DUAN X, Ye D, Yuan J, Guan B, et al
    COL5A1 overexpression correlates with poor prognosis in human cervical cancer.
    Int J Biol Markers. 2024 Jul 23:3936155241265976. doi: 10.1177/03936155241265976
    PubMed    
    Abstract available

  289. PETRIK AF, Rivelli JS, Firemark AJ, Johnson CA, et al
    A qualitative assessment of the acceptability of human papillomavirus self-sampling and informational materials among diverse populations.
    Cancer Med. 2024;13:e70033.
    PubMed    
    Abstract available

  290. FENG Y, Li X, Sun F, Zhou J, et al
    Efficacy and Safety Analysis of Recombinant Human Endostatin (Endostar) Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer: A 2-Center Retrospective Study.
    Technol Cancer Res Treat. 2024;23:15330338241263026.
    PubMed    
    Abstract available

  291. LU D, Chen X, Mu Y, Kong L, et al
    Discontinuation and non-publication of randomized controlled trials on cervical cancer or precancer.
    Jpn J Clin Oncol. 2024 Jul 23:hyae096. doi: 10.1093.
    PubMed    
    Abstract available

  292. JANOWSKI EM, Hall E, Jin R, Horton B, et al
    Impact of baseline lymphopenia on outcomes of definitive treatment for locally advanced cervical cancer.
    Gynecol Oncol Rep. 2024;54:101448.
    PubMed    
    Abstract available

  293. FU Q, Chen X, Liu Y, Zhang J, et al
    Improvement of accumulated dose distribution in combined cervical cancer radiotherapy with deep learning-based dose prediction.
    Front Oncol. 2024;14:1407016.
    PubMed    
    Abstract available

  294. BEAUSSIRE-TROUVAY L, Duhamel O, Perdrix A, Leveque E, et al
    Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer.
    Front Oncol. 2024;14:1382008.
    PubMed    
    Abstract available

  295. WEI S, Chen H, Deng X, Jiang P, et al
    A case report of hemophagocytic lymphohistiocytosis induced by toripalimab plus chemoradiotherapy in cervical cancer.
    Heliyon. 2024;10:e33816.
    PubMed    
    Abstract available

  296. RYAN N, Pratiwi SE, Mardhia M, Ysrafil Y, et al
    Immunoinformatics approach for design novel multiepitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer.
    Osong Public Health Res Perspect. 2024 Jul 23. doi: 10.24171/j.phrp.2024.0013.
    PubMed    
    Abstract available

  297. KUMAR A
    Human papillomavirus-16 E6-positive cervical cancer attenuated by potent 2-(4-biphenylyl)-N-(1-ethyl-4-piperidinyl) acetamide second-generation analogs with improved binding affinity.
    Biotechnol Appl Biochem. 2024 Jul 22. doi: 10.1002/bab.2639.
    PubMed    
    Abstract available

  298. GREANEY ML, Cohen SA, Allen JD
    Pap test recency and HPV vaccination among Brazilian immigrant women in the United States: a cross-sectional study.
    BMC Public Health. 2024;24:1954.
    PubMed    
    Abstract available

  299. SIDAWAY P
    Tisotumab vedotin effective in recurrent cervical cancer.
    Nat Rev Clin Oncol. 2024 Jul 22. doi: 10.1038/s41571-024-00929.
    PubMed    


  300. HODNELAND E, Andersen E, Wagner-Larsen KS, Dybvik JA, et al
    Impact of MRI radiomic feature normalization for prognostic modelling in uterine endometrial and cervical cancers.
    Sci Rep. 2024;14:16826.
    PubMed    
    Abstract available

  301. ACHARYA K, Bhattarai N, Dahal R, Bhattarai A, et al
    Examining the availability and readiness of health facilities to provide cervical cancer screening services in Nepal: a cross-sectional study using data from the Nepal Health Facility Survey.
    BMJ Open. 2024;14:e077537.
    PubMed    
    Abstract available

  302. HUSSEIN K, Wafula F, Kassie GM, Kokwaro G, et al
    Barriers and facilitators to implementation of the Ethiopian national cancer control plan strategies: Implications for cervical cancer services in Ethiopia.
    PLOS Glob Public Health. 2024;4:e0003500.
    PubMed    
    Abstract available

  303. GENG B, Oliveira CR, Hosier H, Sheth SS, et al
    Reduction in Unindicated Cervical Cancer Screening in Adolescents in a Large Health Care System.
    J Low Genit Tract Dis. 2024 Jul 23. doi: 10.1097/LGT.0000000000000831.
    PubMed    
    Abstract available

  304. KAJABWANGU R, Bajunirwe F, Izudi J, Bazira J, et al
    Late Stage at Diagnosis of Cervical Cancer and Its Correlates at a Large Regional Referral Hospital in Uganda: A Cross-Sectional Study.
    Cureus. 2024;16:e62702.
    PubMed    
    Abstract available

  305. YANG CY, Chang TC, Chou HH, Chao A, et al
    Evaluation of a novel vaginal cells self-sampling device for human papillomavirus testing in cervical cancer screening: A clinical trial assessing reliability and acceptability.
    Bioeng Transl Med. 2024;9:e10653.
    PubMed    
    Abstract available

  306. MA NN, Wang T, Lv YN, Li SD, et al
    An MRI radiomics-based model for the prediction of invasion of the lymphovascular space in patients with cervical cancer.
    Front Oncol. 2024;14:1394427.
    PubMed    
    Abstract available

  307. MYINT WW, Aggad R, Fan Q, Mendez SE, et al
    Factors Influencing Cervical Cancer Screening Uptake among Reproductive-Aged Filipino Women: Findings from the 2022 Philippines National Demographic and Health Survey.
    Womens Health Rep (New Rochelle). 2024;5:485-494.
    PubMed    
    Abstract available

  308. KAJABWANGU R, Izudi J, Bazira J, Ssedyabane F, et al
    Effect of metabolic syndrome and its components on the risk and prognosis of cervical cancer: A literature review.
    Gynecol Oncol Rep. 2024;54:101438.
    PubMed    
    Abstract available

  309. SOKALE IO, Thrift AP, Montealegre JR, Chido-Amajuoyi OG, et al
    Using Geospatial Analysis to Identify Priority Communities for Cervical Cancer Prevention in Texas.
    AJPM Focus. 2024;3:100247.
    PubMed    
    Abstract available

  310. LU Z, Fan P, Huo W, Feng Y, et al
    Corrigendum to "Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer" [Translational Oncology 44 (2024) 1-10/101923].
    Transl Oncol. 2024;47:102037.
    PubMed    


  311. JIAN X, Zhang J, Huang Y, Duan J, et al
    Early salvage therapy with anti-PD-1 antibody Camrelizumab in patients with advanced cervical cancer: a retrospective study.
    Clin Transl Oncol. 2024 Jul 20. doi: 10.1007/s12094-024-03610.
    PubMed    
    Abstract available

  312. WANG X, Xu L, Chen J, Jin Y, et al
    5-aminolevulinic acid photodynamic therapy inhibits the viability, invasion, and migration of cervical cancer SiHa cells by regulating the miR-152-3p/JAK1/STAT1 axis.
    Photodiagnosis Photodyn Ther. 2024 Jul 18:104283.
    PubMed    
    Abstract available

  313. LE A, Wheeler SB, Lafata JE, Teal R, et al
    Self-Collection for HPV Testing: Potential Issues Related to Performance Measures and Quality Improvement Among Federally Qualified Health Centers.
    J Public Health Manag Pract. 2024;30:688-700.
    PubMed    
    Abstract available

  314. CHEN R, Peng C, Wang Z, Xiao Y, et al
    Effects of vaginal microbiota on human papillomavirus infection and its related diseases.
    Microb Pathog. 2024;193:106761.
    PubMed    
    Abstract available

  315. LI Y, Wan L, Li H, Tang X, et al
    Small molecule NMD and MDM2 inhibitors synergistically trigger apoptosis in HeLa cells.
    Mol Cells. 2024;47:100079.
    PubMed    
    Abstract available

  316. NIAZMAND A, Nedaeinia R, Vatandoost N, Jafarpour S, et al
    The impacts of dipeptidyl- peptidase 4 (DPP-4) inhibitors on common female malignancies: A systematic review.
    Gene. 2024;927:148659.
    PubMed    
    Abstract available

  317. VAHTERISTO M, Leinonen MK, Sarkeala T, Anttila A, et al
    Lower incidence of vaginal cancer after cervical human papillomavirus screening - long-term follow-up of Finnish randomized screening trial.
    Prev Med. 2024;185:108031.
    PubMed    
    Abstract available

  318. TSUCHIDA K, Yoshida D, Shima S, Kusunoki T, et al
    Preliminary result of combined treatment with scanning carbon-ion radiotherapy and image-guided brachytherapy for locally advanced cervical adenocarcinoma.
    J Radiat Res. 2024;65:512-522.
    PubMed    
    Abstract available

  319. J WHITE MP, Stevenson A, Elasifer H, Davies C, et al
    Integrity of RNA in long-term-stored cervical liquid-based cytology samples: implications for biomarker research.
    Biotechniques. 2024;76:245-253.
    PubMed    
    Abstract available

  320. HWANG J, Risica PM, Lamy E, Goedel W, et al
    Association between the social vulnerability index and breast, cervical, and colorectal cancer screening rates in Rhode Island.
    Cancer Causes Control. 2024;35:1143-1149.
    PubMed    
    Abstract available

  321. LI S, Li X, Yang YB, Wu SF, et al
    YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells.
    Apoptosis. 2024;29.
    PubMed    
    Abstract available

  322. CHO HW, Jeong S, Song SH, Kim YT, et al
    A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2.
    J Gynecol Oncol. 2024;35:e52.
    PubMed    
    Abstract available

  323. FUSEGI A, Kanao H, Kamata M, Nishino S, et al
    Clinical implications of the superficial uterine vein pattern for the dissection of the anterior layer of the vesicouterine ligament in radical hysterectomy.
    J Gynecol Oncol. 2024;35:e50.
    PubMed    
    Abstract available

  324. LINDQUIST S, Kjaer SK, Frederiksen K, Ornskov D, et al
    Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study.
    Acta Obstet Gynecol Scand. 2024 Jul 16. doi: 10.1111/aogs.14915.
    PubMed    
    Abstract available

  325. WANG ZY, Li R, Li RZ, Pei KG, et al
    Prognostic value of human papillomavirus cell-free DNA in cervical cancer patients: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;300:211-218.
    PubMed    
    Abstract available

  326. ABU-ZAID A, Baradwan S, Alyafi M, Al Baalharith M, et al
    Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016-2019.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:283-288.
    PubMed    
    Abstract available

  327. KA K, Cordoba A, Cagetti LV, Schiappa R, et al
    Preoperative brachytherapy of early-stage cervical cancer: A multicenter study by the SFRO brachytherapy group.
    Gynecol Oncol. 2024;188:90-96.
    PubMed    
    Abstract available

  328. KOCIAN R, Kohler C, Bajsova S, Jarkovsky J, et al
    Sentinel lymph node pathological ultrastaging: Final outcome of the Sentix prospective international study in patients with early-stage cervical cancer.
    Gynecol Oncol. 2024;188:83-89.
    PubMed    
    Abstract available

  329. O'CONNOR RM, Huang DS, Rimel BJ, Kim KH, et al
    Unmet financial needs among patients crowdfunding to support gynecologic cancer care.
    Gynecol Oncol. 2024;186:199-203.
    PubMed    
    Abstract available

  330. BERGSTEIN A, Huang Y, Hershman DL, Xu X, et al
    Impact of medicaid expansion on cervical cancer screening: A state-specific difference in difference analysis.
    Gynecol Oncol. 2024;189:49-55.
    PubMed    
    Abstract available

  331. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Effectiveness of self-sampling human papillomavirus test on precancer detection and screening uptake in Japan: The ACCESS randomized controlled trial.
    Int J Cancer. 2024;155:905-915.
    PubMed    
    Abstract available

  332. BUDUKH A, Dora T, Sancheti S, Singh V, et al
    Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India.
    Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966.
    PubMed    
    Abstract available

  333. LYNGE E, Bennekou Schroll J, Andersen B, Balasubramaniam K, et al
    Cervical cancer incidence in Denmark: Disentangling determinants of time trend.
    Int J Cancer. 2024 Jul 14. doi: 10.1002/ijc.35081.
    PubMed    
    Abstract available

  334. ALIABADI AR, Wilailak S, McNally O, Berek JS, et al
    Contraceptive strategies for reducing the risk of reproductive cancers.
    Int J Gynaecol Obstet. 2024 May 9. doi: 10.1002/ijgo.15567.
    PubMed    
    Abstract available

  335. LIANG C, Su G, Sun L, Zhao H, et al
    Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: A propensity score-matched real-world analysis.
    Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15388.
    PubMed    
    Abstract available

  336. AGUSTI N, Viveros-Carreno D, Melamed A, Pareja R, et al
    Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer.
    Int J Gynecol Cancer. 2024 Jun 25:ijgc-2024-005570.
    PubMed    
    Abstract available

  337. GUO XM, Roman LD, Matsuo K
    Considerations for route of hysterectomy in low-risk cervical cancer.
    Int J Gynecol Cancer. 2024 Jun 23:ijgc-2024-005745.
    PubMed    


  338. VAN DEN BERG MC, Berg HF, Stokowy T, Hoivik EA, et al
    Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2.
    Int J Gynecol Cancer. 2024;34:993-1000.
    PubMed    
    Abstract available

  339. FRUHAUF F, Cibula D, Kocian R, Zikan M, et al
    Diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer.
    Int J Gynecol Cancer. 2024;34:985-992.
    PubMed    
    Abstract available

  340. AKYILDIZ A, Gultekin M, Yigit E, Demir E, et al
    Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.
    Int J Gynecol Cancer. 2024 Jun 30:ijgc-2024-005419.
    PubMed    
    Abstract available

  341. LINDEGAARD JC, Petric P, Tan LT, Hoskin P, et al
    Are we making progress in curing advanced cervical cancer-again?
    Int J Gynecol Cancer. 2024 Jul 10:ijgc-2024-005572.
    PubMed    
    Abstract available

  342. LEE ST, Lee YL, Chung CH, Chien WC, et al
    Cervical cancer and risk of dementia: real-world insights from a nationwide cohort study in Taiwan.
    Int J Gynecol Cancer. 2024 Jul 23:ijgc-2024-005408.
    PubMed    
    Abstract available

  343. CHUK E, Yu C, Scott AA, Liu ZA, et al
    Clinical outcomes of three vs four fractions of MRI-guided brachytherapy in cervical cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00745.
    PubMed    
    Abstract available

  344. ZHOU Y, Xie Y, Luo Y, Wang S, et al
    SNAI2 enhances HPV?negative cervical cancer cell dormancy by modulating u?PAR expression and the activity of the ERK/p38 signaling pathway in vitro.
    Oncol Rep. 2024;52:104.
    PubMed    
    Abstract available

  345. NI R, Han K, Haibe-Kains B, Rink A, et al
    Generalizability of deep learning in organ-at-risk segmentation: A transfer learning study in cervical brachytherapy.
    Radiother Oncol. 2024;197:110332.
    PubMed    
    Abstract available

  346. YANG W, Jin X, Huang L, Jiang S, et al
    Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population.
    BMC Cancer. 2024;24:776.
    PubMed    
    Abstract available

  347. QIN L, Zhang L
    The predictive value of serum inflammatory markers for the severity of cervical lesions.
    BMC Cancer. 2024;24:780.
    PubMed    
    Abstract available

  348. SERMAN F, Lisembard G, Sahraoui M, Berkhout C, et al
    A transversal cross-sectional study of factors related to HPV vaccination status and cancer screening participation among French women aged 25-40.
    BMC Cancer. 2024;24:807.
    PubMed    
    Abstract available

  349. CONG H, Yang X, Li Z, Li Z, et al
    Salvage radiotherapy for locally recurrent cervical and endometrial carcinoma: clinical outcomes and toxicities.
    BMC Cancer. 2024;24:871.
    PubMed    
    Abstract available

  350. DE LA CRUZ-LOPEZ KG, Alvarado-Ortiz E, Valencia-Gonzalez HA, Beltran-Anaya FO, et al
    Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines.
    BMC Cancer. 2024;24:853.
    PubMed    
    Abstract available

  351. YOU J, Yuan Y, Gu X, Wang W, et al
    Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study.
    BMC Cancer. 2024;24:833.
    PubMed    
    Abstract available

  352. STUART RM, Cohen JA, Kerr CC, Mathur P, et al
    HPVsim: An agent-based model of HPV transmission and cervical disease.
    PLoS Comput Biol. 2024;20:e1012181.
    PubMed    
    Abstract available

  353. HERWEIJER E, Hu K, Wang J, Lu D, et al
    Incidence of oncogenic HPV infection in women with and without mental illness: A population-based cohort study in Sweden.
    PLoS Med. 2024;21:e1004372.
    PubMed    
    Abstract available

  354. NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
    Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
    PLoS One. 2024;19:e0306044.
    PubMed    
    Abstract available

  355. GONG S, Li G, Li D, Liu Y, et al
    The risk for subsequent primary lung cancer after cervical carcinoma: A quantitative analysis based on 864,627 cases.
    PLoS One. 2024;19:e0305670.
    PubMed    
    Abstract available

  356. QI J, Li J, Zhu X, Zhao S, et al
    Endothelial cell specific molecule 1 promotes epithelial-mesenchymal transition of cervical cancer via the E-box binding homeobox 1.
    PLoS One. 2024;19:e0304597.
    PubMed    
    Abstract available

  357. JIN S, Lin F, Yang L, Zhang Q, et al
    Association between dietary folate intake and HPV infection: NHANES 2005-2016.
    PLoS One. 2024;19:e0306636.
    PubMed    
    Abstract available

  358. CASTELLANO T, ElHabr AK, Washington C, Ting J, et al
    Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US.
    PLoS One. 2024;19:e0307282.
    PubMed    
    Abstract available

  359. BALQIS-ALI NZ, Anis-Syakira J, Fun WH, Mohd Said Z, et al
    Achieving cervical cancer elimination: The simulated impacts of HPV vaccination and transitioning from liquid-based cytology to HPV-based screening test.
    PLoS One. 2024;19:e0307880.
    PubMed    
    Abstract available


  360. Retraction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis.
    PLoS One. 2024;19:e0308113.
    PubMed    



Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;